Costa J, Le VL, De Leo A, Ravaioli C, Velasco V, Davidson B, Skeie-Jensen T, Devouassoux-Shisheboran M, Trecourt A, Bartosch C, Rios E, Genestie C, Pautier P, Lebreton C, Guyon F, Babin G, Coindre JM, Le Loarer F, Saut O, Croce S(2025) Deep learning can accurately predict the prognosis of gynecologic smooth muscle tumors of uncertain malignant potential: a multicenter pilot study Lab Invest, 104211(in press) DOI 10.1016/j.labinv.2025.104211, PubMed 40602459
Pradhan M, Kildal W, Vlatkovic L, Tobin KAR, Lindemann K, Kristensen GB, Kleppe A, Askautrud HA(2025) Response to correspondence on prognostic value of tertiary lymphoid structures in molecular subgroups of endometrial carcinoma by Pradhan et al Int J Gynecol Cancer, 35(7), 101970(in press) DOI 10.1016/j.ijgc.2025.101970, PubMed 40592175
Lindemann K, Berton D, Sehouli J, Christensen RD, Altintas S, Knudsen AØ, Heudel PE, Ataseven B, Vergote I, Lindahl G, Lebreton C, Schochter F, Auranen A, Follana P, Madsen K, Selle F, Petersson KS, Joly F, Braicu EI, Mirza MR(2025) NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer Gynecol Oncol, 199, 79-87(in press) DOI 10.1016/j.ygyno.2025.06.008, PubMed 40592025
